Factor XI Inhibitors: Anticoagulation with Minimal Bleeding?
The development of new antithrombotic agents is fundamentally driven by the need to effectively prevent dangerous blood clots (thrombosis) while
Read MoreThe development of new antithrombotic agents is fundamentally driven by the need to effectively prevent dangerous blood clots (thrombosis) while
Read MoreVenous thromboembolism (VTE) encompasses pulmonary embolism and deep vein thrombosis. These conditions carry a significant risk of recurrence, particularly following
Read MoreThrombocytopenia and venous thrombosis present a unique clinical paradox. While low platelet counts typically increase bleeding risk, certain conditions lead
Read MoreSometimes a compression of a vein causes a deep vein thrombosis. The mechanism is by preventing normal blood flow. Stagnant
Read MoreA mesenteric vein clot is part of a group of conditions also known as “clots in unusual locations”. The common
Read MoreKnowing when to transfer a pulmonary embolism (PE) patient is crucial for their well-being. Swift action can be life-saving and
Read MoreTrousseau syndrome are recurrent migratory superficial thrombophlebitis in the context of occult visceral cancer. Recurrent means that it is not
Read MoreIncreased imaging made finding incidental pulmonary embolism more common. According to some data, hundreds of thousands of unexpected PE are
Read MoreObesity is a known risk factor for venous thromboembolism. But treating blood clots in overweight people poses another challenge. In
Read MoreMany doctors recommend staying hydrated to prevent blood clots. These blood clots include pulmonary embolism and deep vein thrombosis. For
Read More